University of Miami Sylvester Comprehensive Cancer Center


 

Advances in the CLL Frontline Therapy: BTK Inhibitors vs. Chemoimmunotherapy, Venetoclax vs. Chemoimmunotherapy

147 views
May 14, 2020
0 Comments
Login to view comments. Click here to Login